What is Bristol-Myers Squibb's revenue?

Bristol-Myers Squibb (BMY) generated $48.5B in revenue over the trailing twelve months, up 1.8% year over year.

Is Bristol-Myers Squibb profitable?

Bristol-Myers Squibb reported $7.3B in net income over the trailing twelve months, a 15.0% net margin.

What is Bristol-Myers Squibb's earnings per share?

Bristol-Myers Squibb's diluted EPS over the trailing twelve months is $3.56.

Where does Bristol-Myers Squibb's income statement data come from?

Every line is extracted from Bristol-Myers Squibb's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Bristol-Myers Squibb BMY Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Total revenue	$48.19B-0.2%	$48.3B+7.3%	$45.01B-2.5%	$46.16B-0.5%
Total cost of revenue	$13.94B-0.2%	$13.97B+30.6%	$10.69B+5.5%	$10.14B+2.0%
Gross profit	$34.26B-0.2%	$34.33B+0.1%	$34.31B-4.7%	$36.02B-1.2%
Gross margin	71.1%0.0pp	71.1%-5.2pp	76.2%-1.8pp	78%-0.5pp
Research and development	$9.95B-10.8%	$11.16B+20.0%	$9.3B-2.2%	$9.51B-6.7%
Selling, general and administrative	$7.27B-13.6%	$8.41B+8.3%	$7.77B-0.5%	$7.81B+1.6%
Total costs & expenses	$38.87B-31.4%	$56.68B+55.0%	$36.57B-4.9%	$38.45B+0.4%
Income before income taxes	$9.33B+209%	-$8.55B-201%	$8.44B+9.4%	$7.71B-4.8%
Income tax expense	$2.27B+310%	$554M—	——	——
Net income	$7.05B+178%	-$9.02B-212%	$8.03B+26.8%	$6.33B-9.5%
Net margin	14.6%+33.3pp	-18.7%-36.5pp	17.8%+4.1pp	13.7%-1.4pp
Diluted earnings per share	$3.45+177%	-$4.46-216%	$3.86+30.8%	$2.95-5.4%
Basic earnings per share	$3.47+178%	-$4.46-215%	$3.88+30.2%	$2.98-5.1%
Acquired IPRD	$3.72B-72.2%	$13.37B+1,365%	$913M+12.0%	$815M-29.7%
Amortization of acquired intangible assets	$3.32B-62.6%	$8.87B-1.9%	$9.05B-5.7%	$9.6B-4.3%
Other income, net (Note 6)	-$725M+18.8%	-$893M-177%	$1.16B—	——
EBITDA	$13.34B+1,175%	$1.05B-94.3%	$18.2B+1.2%	$17.99B-4.2%
EBITDA margin	27.7%+25.5pp	2.2%-38.3pp	40.4%+1.5pp	39%-1.5pp
EBIT	$9.33B+209%	-$8.55B-201%	$8.44B+9.4%	$7.71B-4.8%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Bristol-Myers Squibb.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Bristol-Myers Squibb's revenue?: Bristol-Myers Squibb (BMY) generated $48.5B in revenue over the trailing twelve months, up 1.8% year over year.
Is Bristol-Myers Squibb profitable?: Bristol-Myers Squibb reported $7.3B in net income over the trailing twelve months, a 15.0% net margin.
What is Bristol-Myers Squibb's earnings per share?: Bristol-Myers Squibb's diluted EPS over the trailing twelve months is $3.56.
Where does Bristol-Myers Squibb's income statement data come from?: Every line is extracted from Bristol-Myers Squibb's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.